Lubin Investment · Blog

Philip Morris (PM): Q2 2026 results, my verdict

2026-07-23 ·

PM: see the full analysis on Lubin Investment

Philip Morris reported record revenue of $11.2 billion on July 22, 2026, and earnings above expectations, driven by the shift to smoke-free products (IQOS, Zyn). The business is transforming successfully. But the stock is trading more expensively today than at any other point in the past five years. Here is how I separate the two.

A record quarter, above $11 billion for the first time

Philip Morris International reported second quarter results on July 22, 2026 that beat consensus on both lines of the income statement: adjusted earnings per share of $2.20 versus $2.11 expected, and above all revenue of $11.19 billion, a 2.1% beat that pushed the company, for the first time in its history, above $11 billion in a single quarter. Organic revenue growth came in at 8%, and operating income grew 11%, a faster pace than sales: costs did not just keep up with growth, they were kept below it.

On the back of this quarter, management raised its 2026 adjusted earnings per share guidance to a range of $8.26 to $8.41, with full year organic revenue growth now expected between 5% and 7%. Raising guidance after an already-beat quarter is a clear confidence signal from management about the rest of the year, not just the quarter just reported.

The real driver: the shift to smoke-free

The most important detail of this quarter is not in the total, it is in the mix. So-called smoke-free products (IQOS, the heated tobacco device, and Zyn, tobacco-free nicotine pouches) generated 42% of first-half 2026 revenue, and their revenue grew 14.2% this quarter (11.8% at constant currency), nearly double the growth rate of the company as a whole. IQOS unit shipments rose 7.5%, driven notably by Taiwan, global travel retail and Italy, and IQOS in-market sales grew 5%. Zyn, acquired through the Swedish Match deal in late 2022, shipped 2.9 billion pouches this quarter (+2%), with the launch of a new variant, Zyn Ultra.

Why this detail matters: the bear case on tobacco companies for the past two decades is simple, cigarette volumes decline structurally worldwide as smokers quit or switch to alternatives. Philip Morris does not deny this decline, it anticipates it by becoming the seller of the alternative itself. This is a genuine strategic pivot, not just marketing talk: when 42% of your revenue comes from a category that barely existed fifteen years ago, and that category grows twice as fast as the rest, the nature of the business has changed, even if the name on the label still evokes Marlboro.

What my quality filter says: solid, with two real caveats

On my standard 10-criteria model, Philip Morris validates 7 out of 10 criteria. Net margin (the share of revenue that truly becomes profit) reaches 26.7%, a high level reflecting the pricing power of a company selling a product with price-inelastic demand. Cash return on invested capital comes in at 50.8%, an exceptional figure: every dollar reinvested in the business returns more than half of it in cash each year. Share count stays nearly flat (+0.13% a year), a sign the company is not diluting shareholders to fund its growth.

Two caveats deserve explanation, not just mention. First, five-year sales growth comes in at only 7.3% a year, a pace my filter judges insufficient (the threshold is 10%) for a company billed as transforming: this is the accounting trace of the decline in classic cigarettes, partially offset but not yet erased by smoke-free. Second, net debt equals 4.36 years of free cash flow, an elevated level tracing back to a specific event: the Swedish Match acquisition in late 2022 for roughly $16 billion, largely debt funded, which also explains why free cash flow temporarily dropped to $7.9 billion in 2023 (from $9.7 billion the year before) before climbing back to $10.7 billion in 2025. This is not a recent drift, it is the price paid to acquire Zyn, the franchise now driving growth.

One last technical point sheds light on the business: the net cash conversion cycle (the time between paying suppliers and collecting from customers, converted into cash tied up) comes in at 246 days, and it is shrinking by roughly 4 days a year, a sign of operational improvement. This cycle is structurally long in tobacco: inventory alone accounts for 306 days, because leaf tobacco must be bought and then cured for several years before being turned into cigarettes, an industrial cycle far longer than in most sectors, not to be mistaken for poor inventory management.

The price in three steps

Step one: where does today's price sit in Philip Morris's own history? The P/FCF (share price divided by free cash flow generated per share, a measure of what the market is willing to pay for each dollar of cash produced) stands at 27.9 times. This multiple sits at the 97.8th percentile of the stock's five year history: it has only traded more expensively than this about 2% of the time over the past five years. In other words, Philip Morris has almost never been this expensive before, at least on this measure.

Step two: why this level? Three forces combine. The documented success of the smoke-free pivot (revenue +14.2%, a rare growth narrative for a tobacco company) reassures the market about the business's durability beyond the decline of cigarettes. The 3% dividend yield, with a history of increases every year for more than fifteen years, makes it a favored defensive name at a time when investors are seeking defensive income, a behavior documented by several analysts who list Philip Morris among the stocks to favor in a jittery market. Finally, today's quarter, which beat consensus across the board, reinforces this confidence in real time.

Step three: is it justified? My reasonable buy price model, which projects free cash flow per share five years out, puts the entry price at $91.40 for Philip Morris, against a current price of $191.12, a 52.2% premium under this strict calculation. Part of this premium is warranted: a company successfully pivoting into a double-digit growth business deserves a higher multiple than a classic, purely declining tobacco company. But the size of the premium, at a five year high, while overall sales growth (7.3% a year) still sits below my threshold and debt remains elevated, suggests the market has already largely paid in advance for the pivot's success, leaving little margin for error if the transition were to slow down.

How I read it

Philip Morris illustrates a case I rarely see this clearly: a business genuinely transforming itself (smoke-free is no longer an experiment, it is 42% of revenue and the main growth engine), with today's results confirming that trajectory beyond expectations. On quality, my filter is positive: high margin, exceptional return on capital, controlled dilution. On price, however, the market is no longer betting on the pivot succeeding, it has already largely priced it in, to the point where the stock has almost never been this expensive in five years. These are exactly the two questions I always ask separately before any decision, which is what pushed me to build my analysis tool rather than rely on a single overall score. You can find the full breakdown on the Philip Morris analysis page, an explanation of how to read debt inherited from an acquisition in my guide on debt and the Lubin method, and my methodology.

FAQ

Why is Philip Morris stock so expensive despite results beating consensus?

Because the market has already largely priced in the success of the pivot to smoke-free products (IQOS, Zyn), which grow twice as fast as the company. The current P/FCF sits at the 97.8th percentile of its 5 year history: the stock has almost never been this expensive.

What is Zyn and why does it matter so much for results?

Zyn is a tobacco-free nicotine pouch brand, acquired through the Swedish Match deal in late 2022. It shipped 2.9 billion pouches this quarter and is part of the smoke-free products that make up 42% of first-half 2026 revenue, growing fast.

Why does Philip Morris carry so much debt?

Net debt equals 4.36 years of free cash flow, an elevated level tracing back to the Swedish Match acquisition in late 2022 for roughly $16 billion, largely debt funded. That deal is what brought Zyn on board, now one of the growth engines.

Why does Philip Morris hold so much inventory?

Leaf tobacco must be bought and then cured for several years before being turned into cigarettes, which structurally lengthens the inventory cycle (306 days) compared to most sectors. This is not a sign of poor management, it is a characteristic of the business.

Should I buy Philip Morris stock after these results?

My quality grid is positive (7 out of 10 criteria, high margins and return on capital), but my strict pricing model shows a 52.2% premium, at a five year high. This is not personalized investment advice, do your own research.

PM: see the full analysis on Lubin Investment

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).